Psychedelic drug stocks are surging
Digest more
The AIRFoundry facility — funded by a six-year, $18 million National Science Foundation grant — brings together researchers to design and test lipid nanoparticles that deliver RNA-based therapies.
FDA moves shaping drug development and oversight include new gene therapy guidance, clinical trial transparency efforts, and recent drug approvals.
InvestorsHub on MSN
Novo Nordisk teams up with OpenAI to accelerate drug development
Novo Nordisk (NYSE:NVO) said Tuesday it has entered into a strategic collaboration with OpenAI to deploy advanced artificial intelligence tools across its business, spanning drug discovery through to commercial operations.
Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early testing, smart IP and regulatory planning, and scalable CMC choices can help founders reach first-in-human faster.
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant implications for drug development, offering new ...
He said Bayer will launch “the first fundamentally new herbicide in about 40 years” next year, designed in silico: “It’s lik
Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely lucrative weight-loss drug market, said on Tuesday it is partnering with OpenAI to deploy artificial intelligence across its business,
Andrew Pierce is the senior vice president of discovery and development at a company that claims to be “first end-to-end AI biotech,” but he admits he doesn’t know the first thing about artificial intelligence. “For an older school person like me ...
This deal comes as the total value of AI partnerships takes a 120% uptick year-on-year between 2024 and 2025, as per GlobalData.
From survivorship bias to root causes! Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules, predicting ...
If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.